The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. Only patients with clinically tense symptomatic ascites (shortness of breath, umbilical hernia, abdominal pain and/or distension, and/or limitation of activity) who have either diuretic-resistant ascites or diuretic-intractable ascites are being studied.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
University of Miami Hospital
Miami, Florida, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Oregon Health Sciences University
Portland, Oregon, United States
Medical College of Virginia Hospitals
Richmond, Virginia, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Washington Medical Center
Seattle, Washington, United States
The Toronto Hospital
Toronto, Ontario, Canada